💊 How Amazon's $753M PillPack Bet Could Kill Your Local Pharmacy

In partnership with

Hey Deal Lifters! 👋

Remember when Amazon was "just" an online bookstore? Yeah, neither do CVS and Walgreens after what happened in June 2018... 😅

Picture this: A sandy-haired, thick-glasses-wearing pharmacist walks into an Amazon meeting in Seattle. Six weeks later, he walks out $100 million richer, and the entire pharmacy industry starts sweating bullets. 💦

This is the wild story of how TJ Parker sold PillPack to Amazon for $753 million and why it might be the smartest deal Bezos ever made. 🚀

🎬 The Meeting That Changed Everything

It's May 2018. Parker's getting courted by everyone - Walmart's throwing money at him, Novartis is circling like a vulture, but then... Amazon calls. 📞

The meeting was supposed to be a standard pitch. Instead, it turned into a two-person conversation between Parker and Amazon's VP Nader Kabbani (who's apparently also a concert pianist with the Seattle Symphony - because why not be multi-talented? 🎹).

Here's the kicker: By the end of that meeting, Parker had mentally made his decision. Game over. Amazon wins.

When the deal dropped on June 28, 2018, the stock market had a MELTDOWN 📉:

• CVS shares: TANKED

• Walgreens: PLUMMETED

• Rite Aid: Basically RIP

The damage? $753 million for a company that was bleeding $6 million per month. Sounds crazy? Keep reading... 👀

💰 The Numbers That'll Blow Your Mind

Here's what Amazon actually bought:

• Revenue trajectory: $299M (2018) → $635M (2019) → $1.2B (2020) 📈

• Average customer value: $5,000/year (vs $1,300 for Prime members)

• Target demographic: 50-60 year olds (aka the demographic with MONEY) 💵

• Licenses: 49 states (Hawaii, you're still stuck with CVS 🏝️)

But here's the REAL genius move: Amazon didn't just buy a pharmacy. They bought a Trojan horse into a $500 billion market that's been controlled by the same old players for decades.

The key to a $1.3T opportunity

A new trend in real estate is making the most expensive properties obtainable. It’s called co-ownership, and it’s revolutionizing the $1.3T vacation home market.

The company leading the trend? Pacaso. Created by the founder of Zillow, Pacaso turns underutilized luxury properties into fully-managed assets and makes them accessible to the broadest possible market.

The result? More than $1b in transactions, 2,000+ happy homeowners, and over $110m in gross profits for Pacaso.

With rapid international growth and 41% gross profit growth last year, Pacaso is ready for what’s next. They even recently reserved the Nasdaq ticker PCSO.

But the real opportunity is now, before public markets. Until 5/29, you can join leading investors like SoftBank and Maveron for just $2.80/share.

Invest in Pacaso today.

_{This is a paid advertisement for Pacaso’s Regulation A offering. Please read the offering circular at invest.pacaso.com. Reserving a ticker symbol is not a guarantee that the company will go public. Listing on the NASDAQ is subject to approvals. Under Regulation A+, a company has the ability to change its share price by up to 20%, without requalifying the offering with the SEC.}

🏥 Why This Market is RIPE for Disruption

Let's talk about the current state of pharmacy hell:

• 60% of American adults have a chronic illness

• 40% have TWO or more chronic conditions

• The whole system runs on middlemen (PBMs) who hold everyone hostage

• Ever tried to get a prescription filled? It's like navigating a bureaucratic nightmare 😤

Parker's vision? What if getting your medication was as easy as ordering toilet paper on Amazon?

🎯 The Secret Sauce: It's Not Just About Pills

PillPack isn't just shipping drugs in fancy packets (though those white packets are pretty slick 📦). They built something called PharmacyOS - the iOS of prescription management.

This system:

• Automatically handles refills ✅

• Deals with insurance headaches ✅

• Sends notifications ✅

• Sorts everything so you don't accidentally take your dog's heartworm medication ✅

Translation: They made pharmacy WORK for humans instead of insurance companies.

🥊 The David vs Goliath Moment

Here's where it gets SPICY 🌶️...

In 2016, Express Scripts (the biggest pharmacy middleman) tried to CRUSH PillPack. They threatened to kick them out of their network, which would've killed about 1/3 of PillPack's customers overnight.

Parker's response? He declared war.

The guy hired Obama's former deputy chief of staff, built a literal war room, launched #fixpharmacy, and had customers making videos about how PillPack saved their lives. They worked 16-hour days for over a week.

Result: Express Scripts backed down. 💪

Amazon's reaction: "We NEED this guy on our team."

🚀 What Happens Next? (Spoiler: It's Big)

Since the acquisition, here's what's been cooking:

🏗️ Physical Expansion:

• Building a 175,000 sq ft facility in Phoenix (that's Walmart Supercenter size!)

• Physical pharmacies in 5 states and growing

• Hiring like crazy (50+ open positions)

💼 Insurance Partnerships:

• Blue Cross Blue Shield is in talks (that's 100+ million potential customers)

• Other major insurers circling

🔮 The Future Vision: Imagine logging into Amazon to order your blood pressure medication and getting recommendations for:

• The perfect blood pressure monitor

• Heart-healthy snacks

• Meditation apps

• Exercise equipment

It's not just about pills - it's about owning the ENTIRE health ecosystem.

🎭 The Plot Twist: Amazon's Playing 4D Chess

While everyone's focused on PillPack, Amazon's building a health empire:

• Haven: Joint venture with JPMorgan and Berkshire Hathaway

• Health clinics for employees

• Grand Challenge: Secret AI health projects

• AWS Health: Medical records and data mining

The real question: Is PillPack just the appetizer? 🍽️

💡 Why This Deal is GENIUS (And Terrifying)

For Amazon:

• Entry into $500B market ✅

• Older, loyal customer base ✅

• Recurring revenue model ✅

• Data goldmine ✅

For consumers:

• Actually, functional pharmacy experience ✅

• Potentially lower costs ✅

• Integration with Prime benefits ✅

For traditional pharmacies:

• Existential crisis ✅

• Time to innovate or die ✅

🔥 The Bottom Line

TJ Parker didn't just sell a company - he sold a vision of healthcare that works. And Amazon didn't just buy a pharmacy - they bought a weapon to disrupt one of America's most broken industries.

The question isn't IF Amazon will dominate pharmacy - it's HOW FAST.

Your local CVS might want to start planning its exit strategy... 💀

What do you think, Deal Lifters?

Will Amazon fix healthcare or just make it more convenient to be sick? Drop your hot takes in the comments! 🔥

P.S. - If you're still driving to CVS at 11 PM for emergency Advil, you might want to check out what Amazon's cooking up... Just saying. 😉

Stay lifted,
The Deal Lift Team 📈

What Top Execs Read Before the Market Opens

The Daily Upside was built by investment pros to give execs the intel they need—no fluff, just sharp insights on trends, deals, and strategy. Join 1M+ professionals and subscribe for free.

Join 1M+ professionals and subscribe for free.

Start learning AI in 2025

Keeping up with AI is hard – we get it!

That’s why over 1M professionals read Superhuman AI to stay ahead.

• Get daily AI news, tools, and tutorials

• Learn new AI skills you can use at work in 3 mins a day

• Become 10X more productive

Sign up and start mastering AI